InMed Pharmaceuticals EPS Diluted from Discontinued Operations (Quarterly) Analysis

InMed Pharmaceuticals, Inc. (INM)

1.10 +0.03 (+2.80%) USD | NASDAQ | Jan 16, 16:00

1.10 0.00 (0.00%) After-Hours: 20:00

View EPS Diluted from Discontinued Operations (Quarterly) for INM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Lexaria Bioscience Corp.	--
Xenon Pharmaceuticals, Inc.	--